Diabetes Care 37:16501659 Jabbour SA, Fras JP, Ahmed A et al (2020) Efficacy and safety over 2 years of exenatide plus Dapagliflozin in the DURATION-8 study: a multicenter, double-blind, phase 3, randomized controlled trial
Ann N Y Acad Sci 512:237247
However, under conditions of oxidative stress, Keap1 is modified and disrupted from its interaction with Nrf2, and then Nrf2 is translocalized into the nucleus 11,13
Published 2011
Eligibility Criteria GLP-1 medications, including semaglutide and tirzepatide, are typically prescribed for adults with a BMI of 30 or higher, or 27+ with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol